Narsoplimab-wuug (Yartemlea; Omeros Corp.) for Stem Cell Transplant-Associated Thrombotic Microangiopathy

A monoclonal antibody indicated for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy.